{"id":"W2900369580","doi":"10.1182/blood-2018-99-110858","title":"Ravulizumab (ALXN1210) Versus Eculizumab in Adults with Paroxysmal Nocturnal Hemoglobinuria: Pharmacokinetics and Pharmacodynamics Observed in Two Phase 3 Randomized, Multicenter Studies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Pharmacodynamics; Surrogate endpoint; Clinical endpoint; Internal medicine; Pharmacokinetics; Dosing; Gastroenterology; Phases of clinical research; Clinical trial; Pharmacology; Immunology; Antibody; Complement system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005636767,0.0006735277,0.001264113,0.0002261843,0.0003391556,0.0008675354,0.0004996639,0.0009397218,0.001487804],"category_scores_gemma":[0.003339988,0.0003993094,0.001419545,0.0003175981,0.0005655335,0.0008753598,0.0002881228,0.001388622,0.0002429672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000652281,"about_ca_system_score_gemma":0.0008815273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003538885,"about_ca_topic_score_gemma":0.000821218,"domain_scores_codex":[0.9978108,0.001476941,0.000179256,0.0002637328,0.000160173,0.0001090411],"domain_scores_gemma":[0.9974776,0.0007755423,0.0009694126,0.0001961724,0.0001668823,0.000414431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8736561,0.01550931,0.01696941,0.0009699409,0.004518616,0.0001497035,0.0003987554,0.0009231549,0.02224227,0.0001774627,0.001167532,0.06331772],"study_design_scores_gemma":[0.452408,0.4832695,0.05197363,0.0001050921,0.003484804,0.0004615613,0.0001329852,0.001737735,0.003811381,0.0002462121,0.002312184,0.00005693828],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950682,0.00278471,0.0004744574,0.0001613111,0.00004306535,0.0007445689,0.0002426018,0.00003567302,0.0004454306],"genre_scores_gemma":[0.9971122,0.0007014446,0.000738041,0.0002778828,0.00007256988,0.0006027031,0.0002656963,0.000007079384,0.000222398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005636767,"threshold_uncertainty_score":0.02981043,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02722015948553447,"score_gpt":0.3312612590890698,"score_spread":0.3040410996035354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}